Saturday, November 18, 2017 4:06:19 PM
Also further proof of from phase 2 studies are nice but what further proof is needed? There isn't an intelligent person out there that doesn't know that SYN's two lead compounds work and work well.
Another concern is that there are other companies that are developing compounds that deal with the same medical problems. One of them is Pfizer developing a compound that treats C.Diff. I believe that the Pfizer compound is a vaccine. Perhaps someone on this board can clarify that.
Recent TOVX News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/26/2024 08:10:34 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/26/2024 04:15:15 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/23/2024 12:20:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 12:10:25 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/18/2024 09:06:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 12:10:34 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/11/2024 12:45:02 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/10/2024 09:03:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:11:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 12:22:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 08:21:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 12:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:05:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 12:20:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 12:20:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 11:30:14 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 11:10:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:05:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 01:10:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:10:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:07:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:01:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:00:19 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM